Discontinuation report LARTRUVO

Last updated on 2020-06-15 History
Report ID 117642
Drug Identification Number 02469227
Brand name LARTRUVO
Common or Proper name OLARATUMAB
Company Name ELI LILLY CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) OLARATUMAB
Strength(s) 500MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size I Vial , 500 MG / 50 ML
ATC code L01XC
ATC description
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-06-04
Actual discontinuation date 2020-06-04
Remaining supply date 2020-06-04
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Lilly Canada’s Customer Response Centre 1-888-545-5972.
Health Canada comments
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-06-15 French Compare
v1 2020-06-15 English Compare